Progress and challenges of personalized neoantigens in the clinical treatment of tumors
Tumors are a serious threat to human health, and tumor treatments have continued to evolve from chemotherapy to targeted therapy, immunotherapy, and individualized immunotherapy. Tumor cells have many mutations that cause the production of neoantigens, which are unique to tumor cells. Tumor neoantig...
Saved in:
Main Authors: | Hongyu Zhang (Author), Xianchao Zhou (Author), Dongliang Liu (Author), Yufei Zhu (Author), Qingyang Ma (Author), Yuchao Zhang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Establishment of a novel tumor neoantigen prediction tool for personalized vaccine design
by: Kai Xin, et al.
Published: (2024) -
Targeting neoantigens for cancer immunotherapy
by: Xuan Zhao, et al.
Published: (2021) -
Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges
by: Zhi Pang, et al.
Published: (2023) -
The Value of Microbes in Cancer Neoantigen Immunotherapy
by: Junrui Tian, et al.
Published: (2023) -
Neoantigen-reactive T cells exhibit effective anti-tumor activity against colorectal cancer
by: Yaojun Yu, et al.
Published: (2022)